Understanding the relationship between DNA methylation and histone lysine methylation  by Rose, Nathan R. & Klose, Robert J.
Biochimica et Biophysica Acta 1839 (2014) 1362–1372
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbagrmReviewUnderstanding the relationship between DNA methylation and histone
lysine methylation☆Nathan R. Rose 1, Robert J. Klose ⁎
Department of Biochemistry, South Parks Road, University of Oxford, Oxford OX1 3QU, UK☆ This article is part of a Special Issue entitled:Methylatio
looking at transcription and beyond.
⁎ Corresponding author. Tel.: +44 1865 613230.
E-mail address: rob.klose@bioch.ox.ac.uk (R.J. Klose).
1 Tel.: +44 1865 613230.
http://dx.doi.org/10.1016/j.bbagrm.2014.02.007
1874-9399/© 2014 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 18 October 2013
Accepted 11 February 2014






Embryonic developmentDNA methylation acts as an epigenetic modiﬁcation in vertebrate DNA. Recently it has become clear that the
DNA and histone lysine methylation systems are highly interrelated and rely mechanistically on each other for
normal chromatin function in vivo. Here we examine some of the functional links between these systems, with
a particular focus on several recent discoveries suggesting how lysine methylation may help to target DNA
methylation during development, and vice versa. In addition, the emerging role of non-methylated DNA found
in CpG islands in deﬁning histone lysine methylation proﬁles at gene regulatory elements will be discussed
in the context of gene regulation. This article is part of a Special Issue entitled: Methylation: A Multifaceted
Modiﬁcation — looking at transcription and beyond.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
DNA can be modiﬁed by the addition of a methyl group to the 5-
position of cytosine. In most vertebrate cell types, cytosinemethylation
is found in the context of CpG dinucleotides, while recently a much
smaller proportion of 5-methylcytosine has been shown to be enzymat-
ically converted to its hydroxymethylated, formylated or carboxylated
derivatives [1–4]. By virtue of the fact that CpG dinucleotides are
symmetrically methylated, this functions as an elegant system during
semiconservative DNA replication to faithfully copy pre-existing CpG
dinucleotide DNA methylation patterns to the daughter strand. This
has established DNAmethylation as an archetypal example of an epige-
neticmodiﬁcation. In general, DNAmethylation is thought to contribute
to the formation of heterochromatic regions in the genome and
transcriptional silencing. In contrast, regions of the genome that are
enriched for non-methylated CpGs, called CpG islands, are associated
with gene promoters and other regulatory features, where they appear
to contribute to a transcriptionally permissive environment [5–9].
Methylation of these CpG island regions is associated with gene silenc-
ing and is a prevalent feature of abnormally silenced genes in cancers.
Within the context of chromatin, DNA methylation does not func-
tion in isolation. Instead, there is a complex interplay between DNA
methylation and histone modiﬁcations, including acetylation, methyla-
tion and ubiquitylation. The relationship betweenDNAmethylation andn:AMultifacetedModiﬁcation—
. This is an open access article underhistone lysine methylation is particularly interesting as the two appear
to be highly interrelated. For example, there is now emerging evidence
that the modiﬁcation state and sequence of DNA can affect the methyl-
ation states on accompanying histones in chromatin, while the histone
lysinemethylation state of chromatin can in turn inﬂuencemodiﬁcation
of the DNA itself. Although histone lysine methylation is conserved
among eukaryotes, the evolution of DNA methylation is more complex
(reviewed in detail by Iyer et al. [8]), being found in some fungi (not
including yeast), heterolobosea and stramenopiles, most plants, and
some metazoans (including vertebrates, sea urchins, sea anemones
and some insects, but not Drosophila or nematodes). Here we will
focus mainly on DNA and histone methylation in mammals, though
the absence of DNA methylation in many species raises interesting
questions about alternative mechanisms governing histone lysine
methylation and its interactions with DNA sequence. More speciﬁcally,
we will explore the relationship between these epigenetic and chroma-
tin based systems in mammals, highlighting some of the most recent
discoveries that have provided fascinating and revealing insight into
how these processes occur at the molecular and cellular level.
2. A direct link between the readers of DNA methylation and the
histone lysine methylation system
5-methylcytosine (5mC) is widespread throughout the mammalian
genome and found on up to 80% of CpG dinucleotides. In human
and mouse, DNA methylation is best known for the roles it plays in
heterochromatin formation at pericentromeric regions, transcriptional
repression on the inactive X chromosome in females, and gene regulato-
ry functions at imprinting control regions in a parent-of-origin speciﬁc
manner. DNA methylation is generally thought to elicit effects thatthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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deacetylation, methylation, and local chromatin compaction. Some, if
not most, of these effects are likely mediated by one of two families of
methylated CpG DNA binding proteins, comprised of the MBD family
(MeCP2 and Mbd1–4) and the BTB/POZ family (Kaiso and ZBTB4/38)
(reviewed in Ref. [10]).
Biochemical work studying methyl-CpG binding proteins over the
past twenty years has revealed that in addition to speciﬁcally associat-
ing with methylated CpG dinucleotides, these proteins also bind to a
multitude of different chromatin modifying enzymes, including histone
deacetylases and histone lysine methyltransferases. For example,
MeCP2 associates with the Suv39h1/2 histone methyltransferases,
which modify histone H3 on lysine at position 9 (H3K9me) [11,12].
Like DNA methylation, H3K9me is generally associated with transcrip-
tionally repressed gene regulatory elements and heterochromatic
regions of the genome. Fittingly, MeCP2 and H3K9 trimethylation
(H3K9me3) appear concentrated at pericentromeric regions of hetero-
chromatin in cell-based immunostaining experiments.
Mutations in MeCP2 cause the debilitating neurological disease
known as Rett syndrome. Somewhat surprisingly, despite its localiza-
tion to pericentromeric regions of chromatin and its association with
H3K9 methyltransferase activity, cells from a mouse model of Rett
Syndrome lackingMeCP2 do not show obvious defects in H3K9me3 de-
position at pericentromeric regions [13]. This indicates that although
MeCP2 associateswithH3K9methyltransferase activity, this interaction
is not essential for H3K9me3 at major satellite pericentromeric hetero-
chromatin and suggests that the H3K9me3 modiﬁcation state must be
achieved through redundant or mechanistically distinct processes.
One possibility is that multiple MBD proteins may function in a
redundantmanner to driveH3K9me to regions containingDNAmethyl-
ation. In keeping with this idea, the Mbd1 protein can also associate
with H3K9methyltransferase activity. In the case of Mbd1, the associat-
ed activity was attributed to the Setdb1 methyltransferase and this
interactionwas proposed to play an essential role in the correctmainte-
nance of H3K9methylation in heterochromatin during DNA replication.
This function is mediated by a protein complex consisting of Mbd1,
Setdb1 and the chromatin assembly factor Caf1 that assembles during
S-phase of the cell cycle to ensure correct placement of H3K9
methylation during replication-coupled chromatin assembly [14].
Mbd1 is also reported to associate with Suv39h1/HP1 to coordinate
DNA methylation and H3K9 methylation [15], suggesting that it may
play multiple roles in H3K9me deposition. However, deletion of the
Mbd1 protein in mouse does not lead to catastrophic developmental
defects and instead the mice display only mild neurological defects,
though some retrotransposon reactivation was observed [16]. This
suggests that the replication-dependent activity leading to deposition
of H3K9me by Mbd1 is not essential in mouse.
Together, these observations suggest that either the MBD proteins
play partially redundant roles in specifying H3K9me deposition at re-
gions with DNAmethylation during development, or that other parallel
targeting mechanisms can compensate in their absence in knockout
mouse models. Nevertheless, when DNA methylation is lost in cancer
cells lacking the major cellular DNA methyltransferase, Dnmt1, there
are decreases in H3K9me3/me2 levels at heterochromatic regions
[17]. However, when all three mammalian DNMTs are lost in mouse
embryonic stem cells, H3K9 methylation distribution appears broadly
unchanged in sub-nuclear localisation, and proviral sequences which
are normally silenced by H3K9 methylation are not reactivated
[18,19]. This suggests that DNA methylation may play an important
role in specifying how andwhere H3K9me is placed, but that this is like-
ly context-dependent. Interestingly, it is also now becoming clear that
H3K9 methylation plays important roles in the maintenance of DNA
methylation (see Subsection 3.5). Therefore, it appears clear that the
interplay between DNA and histone methylation cannot solely be
accounted for by a simple linear pathwaywherebyMBDproteins recruit
histone methyltransferases to chromatin.3. Getting DNA methylation where it needs to go
Controlling the timing and placement of DNAmethylation in the ge-
nome is essential for normal development and cellular function. DNA
methylation is catalysed by three active DNA methyltransferases
(DNMTs), none of which has signiﬁcant inherent sequence speciﬁcity
beyond the CpG dinucleotide, implying that their targeting to particular
genomic loci must be achieved by other means. These may include the
exclusion of DNA methylation by DNA-bound transcription factors, or
interference by the transcriptional machinery itself, or the effects of
nucleosome positioning and histone modiﬁcations. Recently, it has
become clear that the histone methylation state of chromatin may
have more profound roles than previously realised in the targeting of
DNMTs in mammalian genomes.
Of the three DNMTs found in mammals, Dnmt1 is generally consid-
ered to act as a ‘maintenance’ methyltransferase. It recognises
hemimethylated CpG sites resulting from the synthesis of the daughter
strand following semi-conservative DNA replication and modiﬁes these
to effectively reinstate the methylation patterns that originated in the
parental strands. Dnmt3a and Dnmt3b are highly homologous de novo
methyltransferases (though several splice variants of each enzyme
exist, some of which are catalytically inactive) that are thought to catal-
yse the methylation of CpG at previously non-methylated sites. The
most profound examples of de novo methylation by Dnmt3a/b occur
in two phases in early mouse development (recently reviewed in Ref.
[20]). The ﬁrst occurs following the global demethylation event that
precedes embryo implantation, and the second following a similar
wave of demethylation in developing primordial germ cells (PGCs). In
the zygote, the paternal pronucleus appears to undergo a phase of
rapid global demethylation (with the exception of paternal imprinted
loci) in a process dependent on Tet3 [21,22] and the base excision repair
(BER) machinery [23]. In contrast, the maternal pronucleus is
demethylated more slowly, which may occur via a passive mechanism
related to DNA replication [24]. DNA methylation is then re-
established by Dnmt3a/b, beginning in the inner cell mass of the devel-
oping embryo. Interestingly, the latter wave of de novomethylation in
PGCs also depends on the catalytically inactive Dnmt3 homologue,
Dnmt3L (see Subsection 3.3). The capacity of Dnmt3a/b to recognise
and methylate the appropriate regions of the genome is thus a critical
mechanism in establishing the mammalian epigenome that will be
faithfully maintained by the maintenance methyltransferase Dnmt1.
Perhaps unsurprisingly, given the challenging nature of studyingmolec-
ular mechanisms in the early developingmouse embryo, there remains
very littlemechanistic understanding of how targeting of de novometh-
ylation occurs. Nevertheless, there has recently been a series of ad-
vances that suggest that de novomethylation may rely, at least in part,
on pre-existinghistone lysinemethylation, and in some cases on the en-
zymes that catalyse lysine methylation or demethylation. Furthermore,
lysine methylation also appears to play a role in protecting DNA from
active demethylation.
3.1. The H3K9 methylation system and de novo methylation
Studies aimed at understanding how DNA methylation is speciﬁed
in lower eukaryotes have been instrumental in identifying general
targeting mechanisms that might be shared across species. This has
revealed that targeting of DNA methylation to heterochromatin by the
de novomethyltransferases Dnmt3a/b is dependent, in some contexts,
on pre-existing H3K9 methylation. For example, in the ﬁlamentous
fungus Neurospora crassa all DNA methylation depends on H3K9
methylation [25,26], while a similar requirement has been observed in
Arabidopsis thaliana [27,28] for CpNpG methylation deposited by
CHROMOMETHYLASE3. Several instances of direct interactions between
Dnmt3a/b and the histone H3K9methyltransferase enzymes have been
reported in mammals, though in most cases, the details of how these
interactions mediate DNA methylation are yet to be elucidated. For
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establishment of DNA methylation at pericentric heterochromatin
through their enzymatic placement of H3K9me3 [29]. Accordingly,
Dnmt3a/b are recruited to H3K9-methylated heterochromatin by direct
interactions with heterochromatin protein 1 (HP1), which binds to
H3K9me3 through its chromodomain [29] (though one report has
suggested that Dnmt3a can also displace HP1 from chromatin by
competition for binding to the histone H3 tail [30]). This suggests, at
least in heterochromatin, that H3K9me3 plays a role in targeting DNA
methylation.
Interestingly, it also appears that Dnmt3a/bmay take someguidance
in recognising chromatin substrates through directly interacting with
histone methyltransferases themselves [31]. Dnmt3a/b have been
shown to interact with Suv39h1 [32] and Setdb1 [33] via their ADD do-
main. In the case of Setdb1, this association was essential for methyla-
tion and repression of certain CpG-methylated promoters in cancer
cells. Furthermore, Dnmt3a interacts with the euchromatin-associated
H3K9 methyltransferases G9a/GLP, probably via the chromodomain
protein MPP8 [34]. In this speciﬁc instance the interaction appears to
be Dnmt3a-speciﬁc, as neither Dnmt3a2 nor any of the Dnmt3b splice
variants contain the protein sequence shown to interact with MPP8.
Also, a direct interaction between the C-terminal catalytic domains of
Dnmt3a/b and the ankyrin repeat domains of G9a [35], which are them-
selves able to bind toH3K9methylation, has been shown to play roles in
de novomethylation [36]. The association of the DNMT enzymes with
histone methyltransferases is also reported to extend to the mainte-
nance methyltransferase Dnmt1 which associates with G9a [37].
Although a multitude of observations suggest that either the pres-
ence of H3K9 methylation or direct association of the DNMTs with
H3K9 methyltransferases might play a central role in targeting de novo
DNAmethylation at heterochromatic regions, the precisemolecular de-
tails of these relationships remain poorly understood (Fig. 1). For exam-
ple, do the interactions of Dnmt3a/b with histone methyltransferases
contribute to (i) the allosteric activation of Dnmt3a/b by interactions
with the lysine methyltransferases, (ii) recruitment to correct genomic
loci by interactions with H3K9 methylation, either through HP1 or the
SET-domain methyltransferases themselves, or (iii) methylation of
Dnmt3a/b themselves, either to activate or to promote interactions
with histonemethyltransferases? As it stands now, some of these ques-
tions appear to have contradictory answers with the requirement for
G9a–Dnmt3a/b interactions in establishing DNA methylation in some
cases not requiring the catalytic activity of G9a [35]. However, in other
cases it has been reported that the G9a–Dnmt3a/b interaction itself isFig. 1. Targeting of DNAmethylation and H3K9methylation to (a) heterochromatin, where it in
H3K36 methylation to target DNA methylation to these regions. Several alternative but not mumediated by G9a-catalysed methylation of lysine residues in Dnmt3a
[34]. The situation is further complicated by the complex alternative
splicing that gives rise to variants of the Dnmt3a/b proteins. Studies
linking Dnmt3a/b to H3K9methylation have, in general, not drawn dis-
tinctions between Dnmt3 splice variants, and their possible roles in in-
teractions with H3K9 methyltransferases, HP1 and H3K9 methylation
itself. In order to address these questions, amore deﬁned understanding
of the biochemical nature of DNMT3 protein complexes is required,
coupled to dissection of how these activities function in vivo (Fig. 1).3.2. The H3K36 methylation system and de novo methylation
Several studies have suggested a link between H3K36me3 and de
novoDNAmethylation. H3K36 trimethylation (H3K36me3) is catalysed
by Setd2 [38], which associates with the C-terminal domain of elongat-
ing RNA PolII through a phosphorylation-dependent interaction, and is
targeted to the body of actively transcribed genes [39]. Within gene
bodies, H3K36 methylation is enriched in exons relative to introns
[40–43], and correlateswith enrichment of DNAmethylation anddeple-
tion of histone acetylation [44]. A combination of DNAmethylation and
histone methylation in gene bodies seems to work synergistically to
regulate the splicingmachinery (see Ref. [45] for review). This potential
relationship between DNA methylation and H3K36me3 is further sup-
ported by the observation that the bodies of actively transcribed genes
in the mouse oocyte attract high levels of DNA methylation [46]. This
is in contrast to the rest of the oocyte genome, which differs from
most somatic cells in that it is largely hypomethylated. This interesting
correlation betweenH3K36methylation andDNAmethylation suggests
that mechanisms might exist whereby H3K36 methylation can play a
role in recruiting Dnmt3a/b to gene bodies, or vice versa. In support of
this, Dnmt3a/b contain, in addition to the histone-binding ADD domain,
a PWWP domain, which preferentially binds to H3K36me3 [47]. Muta-
tion of the PWWPdomain inhibits its DNAmethyltransferase activity on
nucleosomal substrates in vitro [47] and leads to reduced afﬁnity of
Dnmt3a/b for nucleosomes [48]. Somewhat surprisingly, based on its
proposed H3K36me3 binding activity, loss of the PWWP domain also
abrogated the ability of Dnmt3a/b to bind to pericentric heterochroma-
tin and its ability to methylate major satellite repeats in pericentric het-
erochromatic regions of the genome [49,50]. This was unexpected,
given that these regions of the genome are not generally thought to
contain signiﬁcant amounts of H3K36me3 methylation. This suggests
that the PWWP domain may play more complex roles in regulatingteracts with the H3K9methylation system, and (b) gene bodies, where itmay interactwith
tually exclusive models are shown here.
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H3K36me3.
Nevertheless, the importance of the PWWP domain for Dnmt3
function is highlighted by the fact that mutations of the PWWP domain
of Dnmt3b have been associated with ICF syndrome (Immunodeﬁcien-
cy, Centromere instability and Facial anomalies syndrome), a severe
autosomal recessive disease in humans. ICF syndrome patients carrying
the PWWP domain mutation lose DNA methylation in the classical
satellite repeat II, consistent with PWWP domain mutations affecting
methyltransferase activity in vitro [51]. However, these studies were
carried out before the PWWP interaction with H3K36me3 was
characterised, so it remains unknown if these outcomes are due to fail-
ure to bind H3K36me3 or are the result of other less well-characterised
chromatin interactions. It would be interesting to examine ICF
syndrome patients with PWWP mutations for alterations in gene
body DNA methylation at actively transcribed genes using modern
genome-wide methylation proﬁling techniques, as has recently been
done for another ICF patient cell line [52]. However, the relationship
between H3K36me3 and DNMT3 recruitment might not be so simple,
as reduced H3K36me3 mediated by knockdown of the histone
lysine methyltransferase Setd2 in a cancer cell line showed no effect
on DNA methylation in gene bodies despite the loss of H3K36me3 in
these regions [53]. If H3K36me3 does have a role in recruiting DNA
methylation, it likely functions in speciﬁc genomic contexts, and further
work is needed to elucidate the mechanisms responsible. It is also pos-
sible that the PWWP domain interacts with other lysine methylation
marks in a context-dependent mechanism to recruit Dnmt3a/b to
heterochromatin.
3.3. A role for H3K4 methylation in blocking DNA methylation
Several observations suggest that histone methylation may play a
role not only in recruiting DNAmethylation to certain genomic regions,
but also in excluding it from others. One such modiﬁcation, H3K4me3,
appears to be mutually exclusive with DNA methylation and therefore
may be a candidate DNA methylation-blocking histone modiﬁcation
[54]. A hint as to why H3K4me3 might block de novo methylation
came from the discovery that the Dnmt3-associated protein Dnmt3L
contains an ADD domain that speciﬁcally interacts with unmodiﬁed
H3K4, and which is blocked from binding the H3 tail when H3K4 is
methylated [55]. In support of a potential role for Dnmt3L in regulating
DNA methylation by the de novo DNMTs, Dnmt3a/b appear to rely in
some contexts, particularly in thewave of DNAmethylation in develop-
ing PGCs, on the function of Dnmt3L. Indeed, the phenotype of a condi-
tional Dnmt3a knockout is very similar to that of Dnmt3L knockout
mice in that Dnmt3L−/− males are sterile, and completely lack
germ cells, while the heterozygous offspring of Dnmt3L−/− females
die in mid-gestation due to abnormal expression of imprinted genes
[56–59]. The observation that Dnmt3L is able to bind to non-
methylated H3K4 but cannot bind to H3K4me3 suggested that H3K4
methylation may play a role in blocking de novo DNA methylation at
some genomic loci [30,55]. Interestingly, the antagonistic effects of
H3K4me3 on DNAmethylation are phenocopied when Dnmt3a is ectop-
ically expressed in budding yeast, a fungus that lacks endogenous DNA
methylation. In these heterologous experiments both the presence of
Dnmt3L and the histone H3 tail containing residues 1–4 were required
for this effect [60]. Furthermore, mutation of the ADD domain of
Dnmt3L reduced DNA methylation levels, while mutation of the sole
H3K4 methyltransferase in budding yeast, Set1, resulted in a global in-
crease in ectopic DNA methylation. The mechanisms by which
Dnmt3L might stimulate Dnmt3a/b activity are not clear; Dnmt3L
forms a tetrameric complex with Dnmt3a/b, which might promote
Dnmt3a/b activity by stabilising the conformation of the active site
loop of Dnmt3a/b [61] or by preventing the formation of Dnmt3 protein
aggregates [62]. However, this does not explain why binding to
H3K4me0 is important for DNMT3 activity. Further, Dnmt3a/b alsocontain ADD domains which can bind H3K4me0 (which has an alloste-
ric activating effect on catalytic activity in vitro [63]). Thus, while these
observations suggest that H3K4me3 antagonises DNA methylation by
the Dnmt3methyltransferases, and H3K4me0 stimulates it, the mecha-
nisms governing this effect are still unclear.
Consistentwith the role of H3K4me0 in facilitatingDNAmethylation
by Dnmt3a/b/L is the observation that Lsd2-deﬁcient female mice show
amaternal-effect lethal phenotype,withmajor disruption of DNAmeth-
ylation at some imprinted genes (Mest, Grb10, Zac1 and Impact) [64].
Lsd2/Kdm1b is a histone lysine demethylase that removes H3K4me2/
me1, and this observation suggests that removal of histone H3K4meth-
ylation may be required for efﬁcient DNA methylation at certain
imprinted loci. While Lsd2/Kdm1b is not required for embryonic devel-
opment, its paralogue Lsd1/Kdm1a is, and embryos lacking Lsd1 fail to
progress through gastrulation [65]. Signiﬁcant reductions in DNAmeth-
ylation are observed in the Lsd1 mutant mice, though it is unclear
whether the effects of Lsd1 deﬁciency aremediated through an inability
of Dnmt3a/b/L to catalyse 5mC, or via direct effects on the maintenance
methyltransferase Dnmt1,which has been reported to be a substrate for
Lsd1 andwhose stabilitymay be reduced in the absence of Lsd1 (though
this effect appears to be cell-type speciﬁc [169]) [65]. It is also likely that
the effects of H3K4 methylation in excluding the DNA methyltransfer-
ases could be mediated through multiple mechanisms, including its ca-
pacity to act as a docking site for components of the transcription
machinery (e.g. TAF3/TFIID [66]) and theH3K4 lysinemethyltransferase
complexes themselves [67]. Interestingly, H3K4me3 can also act as a
binding site for H3K9me2 demethylases [68]. As Dnmt3a/b appear to
rely in some contexts onHP1-mediated interactionswithH3K9methyl-
ation for their activity and targeting (see Subsection 3.1), this suggests
another means whereby interplay between different histone lysine
methylation sites may inﬂuence DNA methylation.
Finally, the requirement for Dnmt3L-facilitated methylation by
Dnmt3a/b does not seem to be universal. The expression of Dnmt3L is
limited to germ cells and early developmental stages ([69–71], and
reviewed in Ref. [72]), whereas Dnmt3a/b are active in many other ge-
nomic and developmental contexts, implying that their catalytic activity
must be amenable to regulation by other proteins apart from Dnmt3L.
Indeed, recent studies have shown that catalytically inactive splice var-
iants of Dnmt3b (Dnmt3b3 and Dnmt3b4) are able to modulate the ac-
tivity of the Dnmt3a/b in a manner analogous to Dnmt3L [72,73]. The
mechanisms by which this is achieved have not yet been elucidated,
and it is unclear whether this relies on interactions with histone lysine
methylation. It is worth noting, however, that the modulatory effects
of Dnmt3b3/4 rely on the presence of intact PWWP domains.
3.4. The relationship between H3K27 methylation and DNA methylation
Histone lysinemethylation on position 27 of H3 (H3K27me) is asso-
ciated with regions of the genome that are silenced by the polycomb
group of transcriptional repressors. This modiﬁcation is catalysed by
the Ezh1/2 components of the polycomb repressive complex 2 (PRC2).
The relationship between H3K27 methylation and DNA methylation
remains poorly deﬁned. In embryonic stem cells, H3K27me3 is located
in discrete, punctate regions coinciding almost exclusively with CpG
islands, which are generally devoid of DNA methylation. At face value
this might suggest that H3K27me3 and DNA methylation are mutually
exclusive. However, in somatic cell types and cancer cell lines
H3K27me3 is much less restricted to CpG islands and there is extensive
overlap between DNA methylation and H3K27me3 methylation,
suggesting that the two are not incompatible [74,75]. Interestingly,
promoters that are marked with H3K27me3 in embryonic stem cells
are more likely to gain DNA methylation during differentiation and
carcinogenesis than those lacking H3K27me3 [76–78]. One possible ex-
planation for this observation is that silencing of these genes is initiated
by the polycomb repressive complexes in early development, and these
genes then subsequently designated for long term silencing by the
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complexes are not expressed. In support of this possibility, it has been
suggested that PRC2 may recruit DNMTs [79], though a more recent re-
port indicates that Dnmt3Lmay inhibit this interaction, thus preventing
DNAmethylation at regionswhere PRC2 is present [80]. Alternatively, a
recent report suggested that PRC2 may also associate with Tet1 [81],
which catalyses hydroxylation of 5mC andmay act to enforce the exclu-
sion of DNA methylation from CpG island regions that are actively
targeted by polycomb mediated repression in embryonic stem cells.
This could explain why the subset of CpG islands that are heavily occu-
pied by polycomb group proteins in embryonic stem cells are not
subject to encroachment of DNA methylation. Nevertheless, these
interesting relationships between DNA and H3K27 methylation clearly
warrant more careful molecular examination in vivo.
3.5. A complex relationship between maintenance DNA methylation,
histone lysine methylation, and other chromatin modiﬁcations
During DNA replication the maintenance DNA methyltransferase
Dnmt1 functions to speciﬁcally recognise hemimethylated DNA and re-
instate symmetrical CpG methylation on the daughter DNA strands,
while ignoring CpG dinucleotides that that lackmethylation. Somewhat
surprisingly, on naked DNA substrates in vitro Dnmt1 alone has robust
methyltransferase activity toward non-methylated CpG dinucleotides
and, according to some reports, sometimes onlyweak biochemical pref-
erence for hemimethylated CpGs over non-methylated CpGs in vitro
(reviewed in Ref. [82]). This suggests that additional mechanisms
must contribute to Dnmt1's elegant speciﬁcity for hemimethylated
CpG dinucleotides in vivo and inability to de novo-methylate non-
methylated CpG island regions. During DNA replication Dnmt1 associ-
ates with PCNA and a second protein called Uhrf1 at replication forks.
Uhrf1 is an interesting multidomain protein that contains several chro-
matin binding domains, including a tandem Tudor and PHD domain
that together bind H3K9me3/me2/H3K4me0 [83,84], and an SRA do-
main that binds to hemimethylated DNA [85–88]. Importantly, Uhrf1
is absolutely required for efﬁcientmaintenancemethylation, suggesting
it may play an essential role in the Dnmt1 catalytic cycle [89,90].
Several models have been proposed to explain the substrate selec-
tivity and recruitment of Dnmt1. One model involves autoinhibition
of DNA methylation by binding to non-methylated DNA through theFig. 2.Maintenance of DNA methylation and histone methylation at replication forks by Dnmt
through interactionswith PCNA,H3K9me3/me2 andhemimethylatedDNA,where it recruits Dn
newly synthesised chromatin.Mbd1 also recruits Setdb1 to newly synthesised chromatin by inte
(b) Model II: Uhrf1 is recruited to replication forks by interactions with PCNA, hemimethylate
ylated hemimethylated DNA.ZF-CxxC domain of Dnmt1 [91,92], though this has been largely
discounted [93]. A second model (Fig. 2a) invokes the binding of
Uhrf1 to the methylated DNA base in a hemimethylated CpG dinucleo-
tide via its SRA domain allowing Dnmt1 to speciﬁcally methylate the
unmodiﬁed cytosine base on the opposite strand [94,95]. In the latter
case, modelling of the available crystal structures of Dnmt1 and the
Uhrf1 SRA domain bound to CpG dinucleotides suggests that it is unlike-
ly that both molecules can simultaneously engage the same site due to
steric clashes between the two proteins [87,91]. This suggests that
Uhrf1 may act to ﬁrst engage a hemimethylated site which is then sub-
sequently bound by Dnmt1, displacing Uhrf1, before the methylation
reaction can occur [95]. A displacement type mechanism may be medi-
ated through the replication foci targeting sequence (RFTS) domain in
Dnmt1 that normally functions to inhibit catalytic activity [96,97]. This
is supported by reports that Uhrf1 interacts with Dnmt1 through the
RFTS domain [98], and this interactionmay be instrumental in relieving
the autoinhibitory effect onDnmt1,making it competent for DNAmeth-
ylation. However, a more recent report showed that Uhrf1, rather than
interacting directly with Dnmt1, ubiquitylates histone H3K23 using its
C-terminal Ring domain as an E3 ligase [99]. H3K23ub then recruits
Dnmt1 to replication foci through interaction with the RFTS domain. It
is possible that this recruitment by H3K23ub then alleviates the
autoinhibition of Dnmt1. According to this model (Fig. 2b), Uhrf1
engages hemimethylated sites through its SRA domain, whereupon it
ubiquitylates H3K23, recruits Dnmt1, and leads to methylation of the
hemimethylated CpG. Consistent with this recruitment model is the
ﬁnding that a Dnmt1–PCNA fusion protein was able to rescue DNA
methylation defects in Uhrf1−/− cells [100], although this doesn't
explain the autoinhibition effects observed for the RFTS domain.
It was recently shown that the recruitment of Dnmt1 via Uhrf1 still
occurs with SRA domain mutants that lack base-ﬂipping activity [100].
Interestingly, the ability of Uhrf1 to target Dnmt1 activity to replication
foci was lost when Uhrf1 lost both its base-ﬂipping and H3K9me3/me2
binding capacity [100], or its E3 ligase activity [99]. This suggests that
histone methylation at H3K9me3/me2, in addition to recognition of
hemimethylated DNA by Uhrf1, may function synergistically to ensure
correct recruitment of Uhrf1 to the appropriate genomic loci. Following
on from this, Uhrf1-dependent H3K23 ubiquitylation would then func-
tion to recruit Dnmt1 and maintain DNA methylation during S-phase
[100,101]. Another report indicates that Uhrf1, through its PHD domain,1. Two alternative models are shown here. (a) Model I: Uhrf1 localises to replication forks
mt1 andH3K9methyltransferases to replaceDNAmethylation and histonemethylation on
ractionswith Caf1 andmethylatedDNA,where it assists inmaintainingH3K9methylation.
d DNA and H3K9me3/me2, where it ubiquitylates H3K23, which recruits Dnmt1 to meth-
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fect on chromatin structure may play a role in targeting Dnmt1 activity
to heterochromatic regions [102]. Interestingly, the ability to target
Dnmt1 to replication foci is limited to Uhrf1 but not its paralogue
Uhrf2. Although Uhrf2 can associate with Dnmt1, Dnmt3a/b and G9a,
and has similar base-ﬂipping and H3K9me3-binding properties to
Uhrf1, it cannot associate with replication foci or target Dnmt1 there
[103,104], suggesting that the ability to ubiquitylate H3 may be limited
to Uhrf1. Uhrf1 knockdown, or mutation of its H3K9me3/me2-binding
tandem Tudor domain, also reduced the stability of Dnmt1 duringmito-
sis, suggesting anothermechanismwhereby DNAmaintenancemethyl-
ation at heterochromatic regions might rely on recognition of histone
methylation [83,105]. It has also been shown that the stability of
Dnmt1 is regulated through the cell cycle by a phospho/methyl switch;
phosphorylation of Ser143 by AKT1 stabilises Dnmt1 by antagonising
methylation of Lys142 by Set7, which targets Dnmt1 for proteasomal
degradation [106,107]. This leads to accumulation of Dnmt1 during S-
phase. It is possible that some of the cell-cycle speciﬁc effects of Uhrf1
in recruitingDnmt1 to chromatin are in part a result of cell-cycle depen-
dent stability of Dnmt1.
Finally, while the maintenance of DNA methylation during replica-
tion is fairly well understood, many questions remain regarding the
maintenance of histone methylation on newly-synthesised chromatin.
H3K4 and H3K27 methylation appear to be maintained on newly-syn-
thesised DNA by association of the respective methyltransferases (TrxG
and PcG complexes) with DNA through the replication fork [169,170].
By contrast, it seems that Uhrf1 and Dnmt1 contribute to the mainte-
nance of H3K9 methylation through interactions with H3K9 methyl-
transferases [108–110]. There is thus emerging evidence for complex
interactions between histone and DNA methylation in the maintenance
of heterochromatin during DNA replication. To this end, there remains
a need for structural information that describes the molecular relation-
ships and physical interactions between the central players in this sys-
tem, including Dnmt1 and H3K23ub, Uhrf1, PCNA, the nucleosome and
the histone methyltransferases. Furthermore, detailed kinetic studies to
examine the ﬁdelity of DNAmethylation and H3K9methylationmainte-
nance are required to understand how these systems function together.
3.6. H3K9me2 methylation protects DNA from demethylation
Histone modiﬁcations also appear to function in ways that protect
DNA from demethylation. It is proposed that, following fertilisation in
the mouse oocyte, DNA methylation may be counteracted via Tet3-
mediated hydroxylation (and possibly demethylation) in the male pro-
nucleus, with the maternal genome being protected from this activity.
Emerging evidence shows that thematernal genome, and certain pater-
nal imprinted loci, are protected from Tet3-mediated hydroxylation by
the binding of PGC7 to H3K9me2 at these loci [111]. The mechanism
by which PGC7 recognises H3K9me2 and prevents hydroxylation of
5mC to 5hmC has yet to be determined. Histone methylation at H3K9
may also inﬂuence imprinting at other loci by interactions with Zfp57
and Trim28, though the mechanisms governing these interactions are
still to be determined. Initial evidence indicates that they seem to func-
tion by facilitating heterochromatinisation and DNA re-methylation
(rather than protecting from Tet3-mediated hydroxylation) (reviewed
in [112]). To this end, Zfp57 and Trim28 co-exist on chromatin with
H3K9me3, Setdb1, HP1 and Uhrf1, and recruit the DNMTs [113–115].
These observations together suggest that H3K9 methylation plays an
important role in the establishment and maintenance of parent-of-
origin-speciﬁc imprints through a variety of mechanisms.
4. Direct links between non-methylated DNA readers and histone
lysine methylation
While most genomic CpG dinucleotides are methylated, regions of
the genome known as CpG islands generally remain free of DNAmethylation. CpG islands are associated with approximately 70% of
mammalian gene promoters and are also found atmany other gene reg-
ulatory elements including enhancers [5–7]. These non-methylated re-
gions are usually associated with particular histone methylation
signatures, including methylation of H3K4 and H3K27 and the absence
of H3K36 methylation.
Much like theMBD family of proteins that recognisemethylated CpG
dinucleotides, a family of proteins that bind to non-methylated CpG di-
nucleotides has also been discovered [116]. These proteins recognise
non-methylated CpG dinucleotides via a highly conserved ZF-CxxC
DNA binding domain. ZF-CxxC domain-containing proteins are found
in a number of proteins/protein complexes which have the ability to
modify histones or DNA, including Mll1/2, Cfp1, Kdm2a/b, Dnmt1,
Tet1/3 and Mbd1. While these proteins have recently been reviewed
in detail [117], we highlight here the functional links between
ZF-CxxC proteins and histone lysine methylation (Fig. 3).
4.1. CpG islands and the placement of H3K4 methylation
The association of H3K4me3 with active gene promoters is well
documented [118], although the precise mechanisms that lead to its re-
cruitment to these genomic regions, and its function in regulating tran-
scription, still remain unclear. Recent work suggests that H3K4me3 aids
in the association of RNA PolII with promoters via interactions with
the general transcription factor TFIID via the TAF3 subunit [66,119].
Interestingly, most CpG island-associated genes, regardless of their tran-
scriptional state, are also modiﬁed by H3K4me3. This suggests that the
underlying non-methylated DNA state may in some way contribute to
this modiﬁcation proﬁle. Fittingly, most of the mammalian H3K4me3
methyltransferase complexes contain ZF-CxxC domain proteins which
may act as the functional link between the activity of these protein com-
plexes and the speciﬁcation of H3K4me3 at CpG islands [120].
In support of this possibility, recent work has demonstrated that the
ZF-CxxC domainprotein Cfp1 recruits the Set1a/bH3K4methyltransfer-
ase complexes to CpG islands, where they catalyse H3K4me3 [121]. Un-
expectedly, in Cfp1−/− cells the most dramatic defects in H3K4me3
placement were not observed at lowly expressed CpG island associated
genes, but instead a themost highly expressed subset of genes. This sug-
gests a role for Cfp1 in the ampliﬁcation of H3K4me3 at highly
expressed genes as opposed to the more ubiquitous placement of
H3K4me3 at CpG islands. Furthermore, new peaks of H3K4me3 ap-
peared at other regulatory regions such as enhancers in the Cfp1 null
cells.When Cfp1 null cells were reconstitutedwith Cfp1mutant protein
lacking a functional ZF-CxxC domain, Cfp1 rescued the defects in
H3K4me3 at transcribed genes but the intact ZF-CxxC domain was re-
quired to prevent the appearance of ectopic H3K4me3 at other regions
[122]. These observations suggest that DNA sequence and methylation
state work together with transcriptional state to ensure correct targeting
of histone lysinemethylationmarks, rather than amore simplisticmodel
where DNA sequence alone inﬂuences the placement of histone marks.
Consistent with this model is the observation that, while the Kdm2b
ZF-CxxC domain protein is able to recruit the polycomb repressive com-
plex 1 (PRC1) tomost CpG islandpromoters, a repressive polycomb state
(characterised by H3K27me3 and H2AK119ub) is only established at a
small subset of CpG island promoters (see Subsection 4.2), indicating
that other factors also inﬂuence the ability of DNA sequences to affect
the attendant histone marks [123–125].
Although the Set1 complexes are responsible formost H3K4methyl-
ation in mammalian cells [120,126], theMll1/2methyltransferase com-
plexes are also thought to contribute to H3K4me3 at speciﬁc regions of
the genome. For example,Mll1/2methylate less than 5% of H3K4me3 in
mammals, butwere found to be essential for themethylation ofHox loci
[5,127–129] and in mouse embryonic stem cells Mll2 contributes to
H3K4me3 at bivalent (H3K27me3/H3K4me3 positive) gene promoters
[129]. Like Cfp1, the Mll1/2 proteins encode a ZF-CxxC domain that
can bind to non-methylated DNA and in some instances this DNA
Fig. 3. CpG islands are associated with distinctive chromatin environments. (a) CpG islands associated with actively transcribed genes recruit H3K4 methyltransferases (Mll1/2, Set1a/b)
through interactions between ZF-CxxC domains and non-methylated CpG dinucleotides. RNA PolII associates with H3K4me3, while Kdm2a/b remove H3K36me2 from CpG islands. CpG
islands also block DNA methylation by preventing the binding of Dnmt3L/Dnmt3a/b to histone tails that are methylated at H3K4. CpG islands may also recruit Mll translocations in
leukaemia, where they recruit elongation complexes and Dot1L, which catalyses H3K79 methylation. (b) CpG island associated genes may be repressed by the polycomb complexes
PRC1 and PRC2. PRC1 can be recruited to CpG islands via interactionwith Kdm2b to ubiquitylate H2AK119. PRC2 is targeted via unknownmechanisms tomethylate H3K27 at CpG islands,
though it may be excluded from non-CpG island regions by its reduced ability to methylate substrates that have H3K36 methylation.
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example, Mll1 translocations which are involved in many instances of
leukaemogenesis also rely on the ZF-CxxC domain and binding to CpG
islands for the establishment and maintenance of aberrant Hoxa9 gene
expression through the recruitment of transcriptional elongation com-
plexes [130–132]. The recruitment of Mll1 fusion proteins also results
in the recruitment of Dot1L, leading to elevated levels of H3K79me2 at
these loci [133–135]. TET proteins, which contain or interact with ZF-
CxxC domains, may also play a role in recruiting H3K4me3 to CpG
islands. TET proteins are reported to recruit OGT (O-GlcNac transferase)
to CpG islands, which in turn interacts with and glycosylates HCF1, a
component of the Set1a/b and MLL1/2 complexes, suggesting that this
may function as another means to recruit H3K4 methylation to CpG is-
land regions [136–140]. Thus there are several possible pathways by
which non-methylated DNA in CpG islands may function to recruit
H3K4 methylation.
4.2. CpG islands, H3K27 methylation and Polycomb
In contrast to H3K4me3, H3K27me3 is associated with repression of
transcription, although the mechanisms by which this is achieved are
not clear [141]. H3K27me3 seems to promote chromatin compaction
[142], which may be associated with repression, while there is also
evidence that it may be involved in excluding Mediator from gene pro-
moters, thus hindering transcriptional activation [143,144]. H3K27me3
in embryonic stem cells correlates strongly with CpG islands [145], and
anticorrelates with DNA methylation at these regions [74,146]. Never-
theless, the mechanisms governing the placement of H3K27me3 by
polycomb repressive complex 2 (PRC2) in vertebrates are still being elu-
cidated. The PRC2 complex consists of a core complex of Ezh2, the active
methyltransferase component, Eed, Suz12 and Rbap46/48, and a num-
ber of ancillary components including Jarid2, Aebp2 and Phc1–3
[147–155]. None of these proteins has been identiﬁed as having speciﬁc
non-methylated CpG-binding capability, though Jarid2 has someprefer-
ence for binding to GC-rich sequences through its C-terminal region,
which contains an ARID domain and a C5HC2 Zn-ﬁnger domain [147].However, a number of lines of evidence – most notably (i) the acquisi-
tion of H3K27me3 by bacterial non-methylated GC-rich sequences inte-
grated into mouse genomes [156], (ii) the acquisition of H3K27me3 by
CpG islands that have activating sequences removed [156], and (iii) the
anticorrelation of H3K27me3with DNAmethylation [74,146] – point to
the requirement for CpG islands in establishing H3K27me3/polycomb
repressed domains in mammals. In the absence of an obvious DNA-
binding candidate for this role, indirect effects have been suggested,
including the ability of H3K36me2 (which is removed from CpG islands
through interactions with the ZF-CxxC-domain containing proteins
Kdm2a/b, among other mechanisms) to inhibit PRC2 activity
[157,158]. However, it should be noted that, although beyond the
scope of this review, other mechanisms including transcription factor-
speciﬁc mechanisms and interactions with non-coding RNAs have
been posited to account for the recruitment of PRC2 to its target regions
of the genome (see Ref. [159] for a recent review), and it is likely that a
combination of factors, including but not limited to the underlying DNA
sequence and DNA methylation state, is responsible.
4.3. CpG islands and the removal of H3K36 methylation
While H3K4me3 and H3K27me3 are associated with CpG islands,
trimethylation of H3K36 is associated with the bodies of actively
transcribed genes, where it associates with DNA methylation (see
Subsection 3.2). Most of our mechanistic understanding of the H3K36
methylation comes from experiments done in budding yeast that
suggest that it may function to suppress histone exchange in actively
transcribed genes through recruitment of the Rpd3s histonedeacetylase
corepressor complex [160], thus reducing cryptic transcriptional initia-
tion in gene bodies [161]. If similarmechanisms are at play in vertebrate
gene bodies, this activity may be further stabilised through the recruit-
ment of de novo DNA methyltransferases Dnmt3a/b and increased
levels of DNAmethylation via recognition of H3K36me3 [47] (discussed
in Subsection 3.2). In contrast to H3K36me3, dimethylation of H3K36
is abundant throughout the genome (30–50% of histone H3 is
dimethylated at H3K36), but targeting and functions of this modiﬁcation
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contributes to transcriptional quelling, supported by the observation
that, in budding yeast, H3K36me2 is sufﬁcient to suppress cryptic initia-
tion and elicit Rpd3smediated effects [162,163]. Recently it was demon-
strated [123–125,164] that the Kdm2a/b histone demethylases are
recruited via their ZF-CxxC domains to CpG island chromatin, where
they lead to removal of H3K36me2. If H3K36me2 acts at the genome
scale in mammals to quell spurious transcriptional initiation, then the
concerted activity of Kdm2a/b at CpG islands may liberate these regions
from this generalized repression andmake themmore amenable to tran-
scription. Given the broad overlap of CpG islands with gene promoters
and other regulatory features, thismay be ameans to highlight regulato-
ry regions in large and complex vertebrate genomes. In addition to
Kdm2b acting as an H3K36me2 demethylase, it is also able to recruit a
variant PRC1 complex to CpG islands. This may function as a sampling
mechanismwhich provides CpG islands with the opportunity to become
occupied by the polycomb group repressive proteins should they lack
counteracting transcriptional activities [123–125] (see Ref. [159] for a
detailed discussion). Interestingly, the ability of the PRC2 complex to
methylate H3K27me3 is inhibited by nucleosomes that have H3K36
methylation, suggesting that Kdm2b may also function at PRC2-
occupied CpG islands to ensure efﬁcient deposition of H3K27me3.
H3K36 methylation may also be excluded from CpG islands by
H2AK119ub, which is catalysed at these regions by the PRC1 complexes
[165]. Clearly there is much that remains to be understood about the
functionality of the H3K36 methylation system in mammals, but never-
theless it appears, much like othermethylationmarks, to be highly inter-
connected with the DNA methylation and CpG island systems.5. Outlook
Our understanding of the interactions between DNA methylation
and histone modiﬁcations is becoming clearer, as we understand the
molecular mechanisms that lead to their deposition and the precise
biochemistry that underpins their catalysis. We now understand that
non-methylated DNA in CpG islands can act as part of a genomic signa-
ture to recruit H3K4 and H3K27 trimethylation, and to exclude H3K36
methylation, possibly creating chromatin environments unique to
gene regulatory elements that are able to modulate transcriptional
states. Similarly, the maintenance of DNA methylation through replica-
tion is becoming more clearly understood, particularly through under-
standing the role of Uhrf1 in targeting and coordinating this activity
through histone modiﬁcations. Nevertheless, understanding how
de novo DNA methylation is targeted during development remains
poorly understood. Although there are indications that unmodiﬁed
H3K4, H3K9me3 and H3K36me3 are involved in these processes, in
many cases these features appear to be context-speciﬁc, stressing that
additional effort is needed to elucidate the molecular detail underpin-
ning these systems and the generality of their usage. Finally, it seems
likely that functional links between 5-hydroxymethylcytosine and his-
tone lysinemethylationwill be identiﬁed, as exempliﬁed by the discov-
ery that Uhrf1 and MeCP2 can also bind to 5hmC [166,167]. With the
molecular components linking the DNA and histone methylation sys-
tems being rapidly identiﬁed, we are well placed to reveal how these
fascinating systems contribute to genome function.Acknowledgements
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